Stockreport

Daiichi Sankyo: Showing No Signs Of Slowing Down ADC Dominance [Seeking Alpha]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Follow Play 7min Summary Daiichi Sankyo's ADCs, particularly trastuzumab deruxtecan (Enhertu) and datopotamab deruxtecan, are showing promising results in treat [Read more]